Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation

Laurie L. Carr, David A. Mankoff, Bernardo H. Goulart, Keith D. Eaton, Peter T. Capell, Elizabeth M. Kell, Julie E. Bauman, Renato G. Martins

Research output: Contribution to journal › Article › peer-review

333 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation'. Together they form a unique fingerprint.

Medicine & Life Sciences